Skip to main content
. 2006 Dec 13;4(14):505–521. doi: 10.1098/rsif.2006.0186

Table 7.

Mean results of 100 simulations generated by uniformly sampling the antiviral and vaccine efficacies from appropriate ranges as assumed in each scenario. Baseline scenario assumes R0=1.9. The mean number of deceased (Dmean), hospitalized (Hmean), infections (Imean), antiviral treatment (Tmean), antiviral prophylaxis (Pmean) and vaccinated (Cmean) individuals. M, million; na, not applicable; ub and lb, upper- and lower-bound parameters presented in table 1.

combined interventions Dmean Hmean Imean Tmean Pmean Cmean
antiviral–vaccinea
lb: ϵAi, ϵVh=0.3, ϵV∈(0.7, 0.9) 6 60 131 46 69 M 300 M
lb: ϵAi, ϵV=0.7, ϵVh∈(0.3, 0.5) 6 67 147 50 69 M 300 M
ub: ϵAi, ϵVh=0.3, ϵV∈(0.7, 0.9) 5 50 117 58 94 M 300 M
ub: ϵAi, ϵV=0.7, ϵVh∈(0.3, 0.5) 5 56 129 62 94 M 300 M
control measures and antiviralsb
lb: qi, ai, ϵA, ζii=0.8, ϵAh∈(0.3, 0.5) 8 94 207 72 124×108 na
ub: qi, ai, ϵA, ζii=0.8, ϵAh∈(0.3, 0.5) 3 31 102 88 145×108 na
control measures, antivirals and vaccinec
lb: qi, ai, νi, ϵAi, ϵV, ζii=0.8, ϵVh∈(0.3, 0.5) 5 53 116 40 69 M 300 M
ub: qi, ai, νi, ϵAi, ϵV, ζii=0.8, ϵVh∈(0.3, 0.5) 3 26 74 51 41 M 300 M
a

Mean of 100 simulations sampled from ϵV∈(0.7, 0.9) and ϵVh∈(0.3, 0.5).

b

Mean of 100 simulations sampled from ϵAh∈(0.3, 0.5).

c

Mean of 100 simulations sampled from ϵVh∈(0.3, 0.5).